Alternating Electric Field and Notch1 Inhibitor Therapy for Recurrence
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies using Notch1 inhibitors for cancer treatment face challenges such as side effects and tumor recurrence after prolonged alternating electric field therapy, necessitating a more effective and safer approach.
Innovation Solution
Concomitant therapy of alternating electric fields and Notch1 inhibitors, where the latter is administered to enhance the efficacy of electric fields and prevent tumor recurrence by sensitizing cancer cells to the electric fields.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Notch1 inhibitors are used to treat cancer, then cancer cell growth is inhibited, but side effects and tumor recurrence occur
Solution Approach 1:
The patent combines alternating electric field therapy with Notch1 inhibitor treatment to create a synergistic therapeutic approach. The alternating electric field sensitizes cancer cells to Notch1 inhibition, enhancing the overall efficacy while potentially reducing the required dosage of the inhibitor, thereby mitigating side effects and preventing recurrence.
Solution Approach 2:
The patent utilizes alternating electric fields to induce changes in cancer cell parameters, specifically increasing their sensitivity to Notch1 inhibitors. This parameter change allows for enhanced treatment efficacy at lower inhibitor concentrations, reducing toxic effects on normal cells.
2Productivity
If Notch1 inhibitors are administered alone, then cancer cell proliferation is reduced, but tumor recurrence occurs after prolonged therapy
Solution Approach 1:
The alternating electric field is applied to preliminarily sensitize cancer cells to Notch1 inhibition before the inhibitor is administered. This preliminary action enhances the effectiveness of the inhibitor, allowing for sustained suppression of cancer cell proliferation and delaying or preventing tumor recurrence.
3Reliability
If higher doses of Notch1 inhibitors are used to prevent recurrence, then treatment efficacy increases, but side effects increase
Solution Approach 1:
The alternating electric field acts as an intermediary that enhances the sensitivity of cancer cells to Notch1 inhibitors. This intermediary effect allows for the use of lower inhibitor doses to achieve the same therapeutic effect, thereby preventing tumor recurrence while minimizing toxicity to normal cells.
Data Source
AI summary
Disclosed are methods of treating a subject in need thereof comprising applying an alternating electric field, to a target site of the subject in need thereof; and administering a a Notch1 inhibitor or Hes5 inhibitor to the subject in need thereof. Disclosed are methods of preventing cancer recurrence in a subject having cancer comprising: applying an alternating electric field to a target site of the subject in need thereof; and administering a Notch1 inhibitor or Hes5 inhibitor to the subject in need thereof. Disclosed are methods of reducing cancer cell growth comprising: applying an alternating electric field to a population of cells comprising one or more cancer cells; and contacting a Notch1 inhibitor or Hes5 inhibitor to the population of cells. Disclosed are methods of sensitizing cancer cells to an alternating electric field comprising: applying an alternating electric field to a population of cells comprising one or more cancer cells; and contacting a Notch1 inhibitor or Hes5 inhibitor to the population of cells.